Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study
- PMID: 19332714
- PMCID: PMC2677921
- DOI: 10.1200/JCO.2008.21.1425
Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study
Abstract
The Childhood Cancer Survivor Study (CCSS) has assembled the largest cohort to date for assessment of late mortality. Vital status and cause of death of all patients eligible for participation in CCSS was determined using the National Death Index and death certificates to characterize the mortality experience of 20,483 survivors, representing 337,334 person-years of observation. A total of 2,821 deaths have occurred as of December 31, 2002. The overall cumulative mortality is 18.1% (95% CI, 17.3 to 18.9) at 30 years from diagnosis. With time, while all-cause mortality rates have been stable, the pattern of late death is changing. Mortality attributable to recurrence or progression of primary disease is decreasing, with increases in rates of mortality attributable to subsequent neoplasms (standardized mortality ratios [SMR], 15.2; 95% CI, 13.9 to 16.6), cardiac death (SMR, 7.0; 95% CI, 5.9 to 8.2), and pulmonary death (SMR, 8.8; 95% CI, 6.8 to 11.2) largely due to treatment-related causes. In addition, the CCSS has identified specific treatment-related risk factors for late mortality. Radiotherapy (relative risk [RR], 2.9; 95% CI, 2.1 to 4.2), alkylating agents (RR, 2.2; 95% CI, 1.6 to 3.0), and epipodophyllotoxins (RR, 2.3; 95% CI, 1.2 to 4.5) increase the risk of death due to subsequent malignancy. Cardiac radiation exposure (RR, 3.3; 95% CI, 2.0 to 5.5) and high dose of anthracycline exposure (RR, 3.1; 95% CI, 1.6 to 5.8) are associated with late cardiac death. By continued longitudinal follow-up of the cohort and expansion of the cohort to include patients diagnosed between 1987 and 1999, the CCSS will remain a primary resource for assessment of late mortality of survivors of childhood cancers.
Conflict of interest statement
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Figures
![Fig 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2677921/bin/zlj9990983690001.gif)
![Fig 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2677921/bin/zlj9990983690002.gif)
![Fig 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2677921/bin/zlj9990983690003.gif)
![Fig 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2677921/bin/zlj9990983690004.gif)
Similar articles
-
Association of Modifiable Health Conditions and Social Determinants of Health With Late Mortality in Survivors of Childhood Cancer.JAMA Netw Open. 2023 Feb 1;6(2):e2255395. doi: 10.1001/jamanetworkopen.2022.55395. JAMA Netw Open. 2023. PMID: 36763361 Free PMC article.
-
Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study.J Clin Oncol. 2009 May 10;27(14):2319-27. doi: 10.1200/JCO.2008.21.1813. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364957 Free PMC article. Review.
-
Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.J Natl Cancer Inst. 2008 Oct 1;100(19):1368-79. doi: 10.1093/jnci/djn310. Epub 2008 Sep 23. J Natl Cancer Inst. 2008. PMID: 18812549 Free PMC article.
-
Cause of mortality in 5-year survivors of childhood cancer.Pediatr Blood Cancer. 2007 Jun 15;48(7):723-6. doi: 10.1002/pbc.21114. Pediatr Blood Cancer. 2007. PMID: 17226844 Review.
-
Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study.J Clin Oncol. 2001 Jul 1;19(13):3163-72. doi: 10.1200/JCO.2001.19.13.3163. J Clin Oncol. 2001. PMID: 11432882
Cited by
-
Protocol for the 'Supporting Young Cancer Survivors who Smoke' study (PRISM): Informing the development of a smoking cessation intervention for childhood, adolescent and young adult cancer survivors in England.PLoS One. 2024 May 15;19(5):e0299321. doi: 10.1371/journal.pone.0299321. eCollection 2024. PLoS One. 2024. PMID: 38748708 Free PMC article.
-
Chronic Health Conditions and Longitudinal Employment in Survivors of Childhood Cancer.JAMA Netw Open. 2024 May 1;7(5):e2410731. doi: 10.1001/jamanetworkopen.2024.10731. JAMA Netw Open. 2024. PMID: 38728029 Free PMC article.
-
Associations between mitochondrial copy number, exercise capacity, physiologic cost of walking, and cardiac strain in young adult survivors of childhood cancer.J Cancer Surviv. 2024 Apr 18. doi: 10.1007/s11764-024-01590-7. Online ahead of print. J Cancer Surviv. 2024. PMID: 38635100
-
Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study.Front Oncol. 2024 Mar 28;14:1376652. doi: 10.3389/fonc.2024.1376652. eCollection 2024. Front Oncol. 2024. PMID: 38606094 Free PMC article.
-
A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors.Cardiooncology. 2024 Apr 6;10(1):20. doi: 10.1186/s40959-024-00211-7. Cardiooncology. 2024. PMID: 38582914 Free PMC article. Review.
References
-
- Hewitt M, Weiner SL, Simone JV, editors. Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, DC: National Academies Press; 2003. - PubMed
-
- Ries LA, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006.
-
- Li FP, Cassady JR, Jaffe N. Risk of second tumors in survivors of childhood cancer. Cancer. 1975;35:1230–1235. - PubMed
-
- Nicholson HS, Fears TR, Byrne J. Death during adulthood in survivors of childhood and adolescent cancer. Cancer. 1994;73:3094–3102. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical